A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

por Wilkinson, Tom, De Soyza, Anthony, Carroll, Miles, Chalmers, James D., Crooks, Michael G., Griffiths, Gareth, Shankar-Hari, Manu, Ho, Ling-Pei, Horsley, Alex, Kell, Chris, Lara, Beatriz, Mishra, Biswa, Moate, Rachel, Page, Clive, Pandya, Hitesh, Raw, Jason, Reid, Fred, Saralaya, Dinesh, Scott, Ian C., Siddiqui, Salman, Ustianowski, Andy, van Zuydam, Natalie, Woodcock, Ashley, Singh, Dave
Publicado 2023